Abstract Details

Title Long-Term Follow-Up of Immune Thrombocytopenia after Treatment of Multiple Sclerosis Patients with Alemtuzumab in CAMMS223

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 036

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Zurab Nadareishvili, MD, PhD (George Washington University, Department of Neurology)	No disclosure on file
George R. Wilmot, MD, PhD (Emory University Dept of Neurology)	Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.

��ɫ��